Skip to content

Author

T. Mamedov

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jun 2026

A rationally designed Wuhan-sequence-based COVID-19 vaccine that maintained effectiveness against diverse SARS-CoV-2 variants, including Omicron: What was the key to success?

The scientific basis of a plant-produced recombinant COVID-19 cocktail vaccine that demonstrated sustained immunogenicity and cross-variant effectiveness despite being designed from the ancestral Wuhan SARS-CoV-2 sequence is discussed.

T. Mamedov · 0 citations